Literature DB >> 16154331

Delivery of a lentiviral vector in a Pluronic F127 gel to cells of the central nervous system.

Padraig M Strappe1, David W Hampton, Begona Cachon-Gonzalez, James W Fawcett, Andrew Lever.   

Abstract

Lentiviral vectors have been demonstrated as efficient tools for gene delivery to the CNS. We describe a novel approach for vector delivery using the thermoresponsive Gel, Pluronic F127 as a carrier. A HIV-1 lentiviral vector expressing GFP was contained in various concentrations of gel (15, 30 and 40%) and applied to cultures of 293T cells. FACS analysis of cells transduced with 8ng of lentiviral vector revealed a similar transduction efficiency for each Gel concentration compared to vector added to cells without PF127. Primary Rat CNS mixed glial cultures were also transduced with lentiviral vector in 15% Pluronic F127 and results demonstrated a similar transduction efficiency of astrocytes compared to virus without gel and no evidence of cell toxicity or death. Stereotaxic delivery of viral vector in 15% PF127 to the rat brain resulted in transduction of cells, predominantly astrocytes close to the injection site. Pluronic F127 gel delivery of viral vectors to the CNS may provide a platform for localised release particularly in areas of brain or spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154331     DOI: 10.1016/j.ejpb.2005.06.006

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  11 in total

1.  Novel formulations enhance the thermal stability of live-attenuated flavivirus vaccines.

Authors:  O'Neil Wiggan; Jill A Livengood; Shawn J Silengo; Richard M Kinney; Jorge E Osorio; Claire Y-H Huang; Dan T Stinchcomb
Journal:  Vaccine       Date:  2011-07-29       Impact factor: 3.641

Review 2.  Hydrogels in spinal cord injury repair strategies.

Authors:  Giuseppe Perale; Filippo Rossi; Erik Sundstrom; Sara Bacchiega; Maurizio Masi; Gianluigi Forloni; Pietro Veglianese
Journal:  ACS Chem Neurosci       Date:  2011-05-04       Impact factor: 4.418

3.  Adhesive thermosensitive gels for local delivery of viral vectors.

Authors:  Jeanette M Caronia; Daniel W Sorensen; Hope M Leslie; Jop H van Berlo; Samira M Azarin
Journal:  Biotechnol Bioeng       Date:  2019-05-20       Impact factor: 4.530

4.  Assessment and streamlined preparation of low-cytotoxicity lentiviral vectors for mobilized human hematopoietic stem cell transduction.

Authors:  Paul T Toran; Martin Wohlfahrt; Julia Foye; Hans-Peter Kiem; Don M Wojchowski
Journal:  Exp Hematol       Date:  2020-05-27       Impact factor: 3.084

5.  UNC5B Overexpression Alleviates Peripheral Neuropathic Pain by Stimulating Netrin-1-Dependent Autophagic Flux in Schwann Cells.

Authors:  Pei-Yao Xiao; Jing-Yan Chen; Qing Zeng; Zi Huang; Bei-Xu Huang; Jian Yu; Song-Jie Liao
Journal:  Mol Neurobiol       Date:  2022-06-06       Impact factor: 5.682

6.  Sustained, localized transgene expression mediated from lentivirus-loaded biodegradable polyester elastomers.

Authors:  Michele C Jen; Kevin Baler; Ashleigh R Hood; Seungjin Shin; Lonnie D Shea; Guillermo A Ameer
Journal:  J Biomed Mater Res A       Date:  2012-10-15       Impact factor: 4.396

Review 7.  Injectable hydrogels for ophthalmic applications.

Authors:  Kai Wang; Zongchao Han
Journal:  J Control Release       Date:  2017-10-20       Impact factor: 9.776

Review 8.  Gene delivery strategies to promote spinal cord repair.

Authors:  Christopher M Walthers; Stephanie K Seidlits
Journal:  Biomark Insights       Date:  2015-04-09

9.  Influence of Drug-Carrier Polymers on Alpha-Synucleinopathies: A Neglected Aspect in New Therapies Development.

Authors:  C Tonda-Turo; M Herva; V Chiono; G Ciardelli; M G Spillantini
Journal:  Biomed Res Int       Date:  2018-02-21       Impact factor: 3.411

Review 10.  PEO-PPO-PEO Tri-Block Copolymers for Gene Delivery Applications in Human Regenerative Medicine-An Overview.

Authors:  Ana Rey-Rico; Magali Cucchiarini
Journal:  Int J Mol Sci       Date:  2018-03-08       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.